The current P/E ratio of IART cannot be calculated, as the latest EPS of -$0.08 is negative. The most recent PE ratio recorded for Integra Lifesciences Holdings was 97.13 in June 2024.
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 128.17. Analyzing the last ten years, IART's PE ratio reached its highest point in the Sep 2015 quarter at 1,489, with a price of $29.78 and an EPS of $0.02. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
Year | PE ratio | Change |
---|---|---|
2023 | 51.24 | 99.22% |
2022 | 25.72 | -23.22% |
2021 | 33.5 | -18.47% |
2020 | 41.09 | -58.4% |
2019 | 98.78 | 59.89% |
2018 | 61.78 | 8.42% |
2017 | 56.98 | 32.82% |
2016 | 42.9 | N/A |
2015 | N/A | N/A |
2014 | 52.14 | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
CNMD CONMED Corp | 16.75 | $2.22B |
CAH Cardinal Health Inc | 23.83 | $29.87B |
JNJ Johnson & Johnson | 25.79 | $374.39B |
MDT Medtronic plc | 28.44 | $108.68B |
TFX Teleflex Inc | 37.68 | $8.85B |
SYK Stryker Corp | 41.37 | $148.73B |
XRAY DENTSPLY SIRONA Inc | N/A | $3.71B |
IART Integra Lifesciences Holdings Corp | N/A | $1.77B |
The current price to earnings ratio of IART cannot be determined, as its EPS of -$0.08 is negative.
Over the last 3 years, the average PE ratio for IART stock is 40.37.
Over the last 5 years, the average PE ratio for IART stock is 49.08.
Over the last ten years, the quarterly PE ratio reached its highest level at 1,489 in the Sep 2015 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.